Geothermal energy technology developer Fervo has received $28m from investors including Congruent Ventures and Helmerich & Payne.

CAS Investment Management has returned for a $34m series A-plus round that was led by CDH Wealth Management.

Amadeus V Technology Fund has closed with $153m in funding, having already backed multiple spinouts.

Novo Seeds co-led a $61.7m round for the oncology therapy developer to help commercialise research originating at University of Copenhagen and Rigshospitalet.

Stanford University returned for the cryptocurrency exchange infrastructure developer's series B round.

Allied Minds portfolio company OcuTerra Therapeutics has secured $14.6m in funding.

Saint-Gobain has contributed to Richland Capital’s third fund, which had already attracted Tsinghua Asset Management’s Redbud vehicle.

CSIRO-founded Main Sequence Ventures has pocketed $194m for its second fund, which has added decarbonisation to the firm’s list of targeted technologies.

Less than two months after closing a $100m series C round, the Dundee spinout has raised $225m in a series D led by SoftBank Vision Fund 2.

Yale’s immunological and inflammatory disease therapy developer has filed for an offering with an $86.3m placeholder target.